Disease/Infection News

RSS

Quick, forceful implementation of control interventions necessary to control Ebola outbreaks

New Ebola research demonstrates that quick and forceful implementation of control interventions are necessary to control outbreaks and avoid far worse scenarios.

10 Oct 2014

Primerdesign develops simple diagnostic test solution to contain 2014 Ebola outbreak

High-tech British company Primerdesign Ltd, a spin-off company from the University of Southampton, has developed a fast and simple diagnostic test solution specific to the 2014 Ebola outbreak.

10 Oct 2014

Ebola screening and education stepped up amid fears of spiralling epidemic

The recent occurrences of Ebola cases outside Africa has led to fears of a global epidemic. The US Centers for Disease Control and Prevention (CDC) has estimated that the number of infections could rise to up to 1.4 million people by early next year without a massive global intervention to contain the virus.

10 Oct 2014

Researchers explore risks associated with consumption of bat bushmeat

Ebola, as with many emerging infections, is likely to have arisen due to man's interaction with wild animals – most likely the practice of hunting and eating wild meat known as 'bushmeat'. A team of researchers led by the University of Cambridge and the Zoological Society of London has surveyed almost six hundred people across southern Ghana to find out what drives consumption of bat bushmeat – and how people perceive the risks associated with the practice.

10 Oct 2014

Vancomycin drug still effective in treating Staphylococcus aureus bloodstream infections

A University of Nebraska Medical Center research team has determined that a longtime antibiotic, vancomycin, is still effective in treating Staphylococcus aureus bloodstream infections and that physicians should continue to use the drug even though several newer antibiotics are now available in the marketplace.

10 Oct 2014

First study of promising Ebola vaccine commenced in West Africa

Professor Myron M. Levine, MD, Director of the Center for Vaccine Development at the University of Maryland School of Medicine, and UM SOM Dean E. Albert Reece MD, PhD, MBA, announced today that the CVD, in conjunction with its sister institution, The Center for Vaccine Development of Mali and the Ministry of Health of Mali, have begun a clinical trial in health care workers (and other front-line workers) to evaluate a promising experimental Ebola vaccine.

10 Oct 2014

Study suggests that college athletes who play contact sports more likely to carry MRSA

Even if they don't show signs of infection, college athletes who play football, soccer and other contact sports are more likely to carry the superbug methicillin-resistant Staphylococcus aureus (MRSA), suggests a study on MRSA and athletes, which is being presented at IDWeek 2014-.

10 Oct 2014

MSH mobilizes resources to strengthen Liberia’s health system, limit spread of Ebola

Management Sciences for Health (MSH), a Massachusetts-based global health nonprofit organization, today announced it is mobilizing its expertise and resources at the epicenter of the Ebola epidemic in Liberia to help the Ministry of Health develop community care centers for Ebola separate from the health facilities; restore essential health services for non-Ebola patients; and, improve the detection and containment of active Ebola cases in Liberian communities.

9 Oct 2014

Survey shows most Americans support ban on flights arriving from Ebola countries

Fifty-eight percent of Americans support banning all flights to the United States from countries experiencing an Ebola outbreak, according to an exclusive new NBC News scientific survey conducted online by SurveyMonkey.

9 Oct 2014

European experts publish common vision of priorities for marine research

Some 340 European scientists, policy-makers and other experts representing 143 organizations from 31 countries spoke with one voice today, publishing a common vision of today's most pressing marine-related health and economic threats and opportunities.

9 Oct 2014

RBX2660 drug candidate highly effective against recurrent Clostridium difficile infection

Rebiotix Inc. announced today that results of the Phase 2 PUNCH CD Study found that the overall efficacy of RBX2660 in the treatment of recurrent Clostridium difficile infection was 87.1%. The study also found that administration of RBX2660 was well-tolerated and demonstrated satisfactory safety in the 60-day interim analysis.

9 Oct 2014

RPS Diagnostics receives CE mark for FebriDx test

RPS Diagnostics, Inc. today announced CE mark of its FebriDx test, clearing the way for sales in the European Union and all countries recognizing the CE mark.

9 Oct 2014

NanoBio to highlight prophylactic NE HSV-2 vaccine candidate at The Keystone Symposia Conference

NanoBio Corporation today announced that the company will present data at The Keystone Symposia Conference, The Modes of Action of Vaccine Adjuvants, in Seattle on October 12, 2014.

9 Oct 2014

KNCV becomes prime partner for USAID's flagship tuberculosis program

KNCV Tuberculosis Foundation, the Dutch NGO specialized in the fight against tuberculosis, will be the prime partner for the United States Agency for International Development in their new five year flagship program 'Challenge TB'.

9 Oct 2014

Researchers are developing compounds to combat causative agents of periodontitis

A total 12 million Germans suffer from periodontitis. If the inflammation remains untreated, this could lead to tooth loss. However, it is also suspected of triggering many other diseases, like cardiopulmonary diseases. Researchers are studying the interactions, and developing compounds to combat the causative agents.

9 Oct 2014

EPFL scientists discover two molecules that could overcome multidrug resistance in tuberculosis

Using a high-throughput screening assay, EPFL scientists have discovered two small molecules that could overcome the multidrug resistance of the bacterium that causes tuberculosis.

9 Oct 2014

Kansas State professor aims to develop vaccines to protect against tick-borne diseases

A Kansas State University professor is researching ways to keep animals and humans safe from tick-borne diseases.

9 Oct 2014

Molecular biologists awarded NIH grant to identify new compounds to fight malaria parasite

A team of molecular biologists, jointly led by Clemson University professor Jim Morris, was awarded a $151,121 grant from the National Institutes of Health to identify new compounds with anti-malarial activity for a deadly parasite species that kills hundreds of thousands of people each year.

9 Oct 2014

Journal of Disaster Medicine and Public Health Preparedness launches special issue on Ebola

The Society for Disaster Medicine and Public Health is committed to examining the details of individual disasters and public health crises. With the recent arrival of Ebola in the United States, the journal is launching a special issue on the virus. The journal will serve as an educated and authoritative voice on the virus, risk and threat level, potential of outbreak, preparation and response for the public and media.

9 Oct 2014

TGen, NAU awarded patent for genomics-based test to detect H1N1 pandemic flu strain

The federal government has awarded a patent to the Translational Genomics Research Institute and Northern Arizona University for a test that can detect — and assist in the treatment of — the H1N1 pandemic flu strain.

9 Oct 2014

Disease/Infection News

Quick, forceful implementation of control interventions necessary to control Ebola outbreaks

Primerdesign develops simple diagnostic test solution to contain 2014 Ebola outbreak

Ebola screening and education stepped up amid fears of spiralling epidemic

Researchers explore risks associated with consumption of bat bushmeat

Vancomycin drug still effective in treating Staphylococcus aureus bloodstream infections

First study of promising Ebola vaccine commenced in West Africa

Study suggests that college athletes who play contact sports more likely to carry MRSA

MSH mobilizes resources to strengthen Liberia’s health system, limit spread of Ebola

Survey shows most Americans support ban on flights arriving from Ebola countries

European experts publish common vision of priorities for marine research

RBX2660 drug candidate highly effective against recurrent Clostridium difficile infection

RPS Diagnostics receives CE mark for FebriDx test

NanoBio to highlight prophylactic NE HSV-2 vaccine candidate at The Keystone Symposia Conference

KNCV becomes prime partner for USAID's flagship tuberculosis program

Researchers are developing compounds to combat causative agents of periodontitis

EPFL scientists discover two molecules that could overcome multidrug resistance in tuberculosis

Kansas State professor aims to develop vaccines to protect against tick-borne diseases

Molecular biologists awarded NIH grant to identify new compounds to fight malaria parasite

Journal of Disaster Medicine and Public Health Preparedness launches special issue on Ebola

TGen, NAU awarded patent for genomics-based test to detect H1N1 pandemic flu strain

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News